Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to -0.05%.

  • Immunocore Holdings' Return on Capital Employed rose 4.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year increase of 4.00%. This contributed to the annual value of -0.12% for FY2024, which is 2.00% up from last year.
  • Immunocore Holdings' Return on Capital Employed amounted to -0.05% in Q3 2025, which was up 6.76% from -0.05% recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Return on Capital Employed peaked at -0.05% during Q3 2025, and registered a low of -0.11% during Q1 2024.
  • Over the past 2 years, Immunocore Holdings' median Return on Capital Employed value was -0.08% (recorded in 2024), while the average stood at -0.08%.
  • Data for Immunocore Holdings' Return on Capital Employed shows a peak YoY grew of 6bps (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Immunocore Holdings' Return on Capital Employed stood at -0.08% in 2024, then increased by 4bps to -0.05% in 2025.
  • Its Return on Capital Employed stands at -0.05% for Q3 2025, versus -0.05% for Q2 2025 and -0.05% for Q1 2025.